Prophylaxis of nausea and Vomiting after laparoscopic cholecystectomy with ramosetron: Randomised controlled trialFUJII, Yoshitaka; UEMURA, Aki; TANAKA, Hiroyoshi et al.The European journal of surgery. 2002, Vol 168, Num 11, pp 583-586, issn 1102-4151, 4 p.Article

Comparison of ramosetron with combined ramosetron and midazolam for preventing postoperative nausea and vomiting in patients at high risk following laparoscopic gynaecological surgeryEUN YOUNG PARK; SOO KYUNG LEE; MAE HWA KANG et al.Journal of international medical research. 2013, Vol 41, Num 3, pp 654-663, issn 0300-0605, 10 p.Article

Ramosetron, midazolam, and combination of ramosetron and midazolam for prevention of postoperative nausea and vomiting: A prospective, randomized, double-blind studyWON JOONG KIM; HYUN KANG; HWA YONG SHIN et al.Journal of international medical research. 2013, Vol 41, Num 4, pp 1203-1213, issn 0300-0605, 11 p.Article

Ramosetron for the management of chemotherapy-induced gastrointestinal events in patients with hematological malignanciesZENG, X. Y; WANG, A. H; LIU, Y. F et al.Methods and findings in experimental and clinical pharmacology. 2001, Vol 23, Num 4, pp 191-195, issn 0379-0355Article

Prophylactic control of post-operative nausea and vomiting using ondansetron and ramosetron after cardiac surgeryCHOI, D. K; CHIN, J. H; LEE, E. H et al.Acta anaesthesiologica scandinavica. 2010, Vol 54, Num 8, pp 962-969, issn 0001-5172, 8 p.Article

A randomized clinical trial of a single dose of ramosetron for the prevention of vomiting after strabismus surgery in children: A dose-ranging studyFUJII, Yoshitaka; TANAKA, Hiroyoshi; ITO, Mutsuko et al.Archives of ophthalmology (1960). 2005, Vol 123, Num 1, pp 25-28, issn 0003-9950, 4 p.Article

Randomized, double-blind, placebo-controlled, dose-finding study of the antiemetic effects and tolerability of Ramosetron in adults undergoing middle ear surgeryFUJII, Yoshitaka; TANAKA, Hiroyoshi.Clinical therapeutics. 2003, Vol 25, Num 12, pp 3100-3108, issn 0149-2918, 9 p.Article

Comparison of the selective serotonin₃ antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea, and anorexia : A single-blind, randomized, crossover studyFENG YI FENG; PIN ZHANG; YOU JIAN HE et al.Current therapeutic research. 2000, Vol 61, Num 12, pp 901-909, issn 0011-393XArticle

Comparison of ramosetron and granisetron for preventing postoperative nausea and vomiting after gynecologic surgeryFUJII, Y; SAITOH, Y; TANAKA, H et al.Anesthesia and analgesia. 1999, Vol 89, Num 2, pp 476-479, issn 0003-2999Article

Involvement of the 5-HT₃ receptor in CRH-induced defecation in ratsMIYATA, K; ITO, H; FUKUDO, S et al.American journal of physiology. Gastrointestinal and liver physiology. 1998, Vol 37, Num 5, pp G827-G831, issn 0193-1857Article

Ramosetron, dexamethasone, and their combination for the prevention of postoperative nausea and vomiting in women undergoing laparoscopic cholecystectomyYOUN YI JO; JONG WHA LEE; JAE KWANG SHIM et al.Surgical endoscopy. 2012, Vol 26, Num 8, pp 2306-2311, issn 0930-2794, 6 p.Article

Comparison of Ramosetron, Dexamethasone, and a Combination of Ramosetron and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Korean Women Undergoing Thyroidectomy: A Double-Blind, Randomized, Controlled StudyJEON, Younghoon; KIM, Hyunjee; KWAK, Kyung-Hwa et al.Current therapeutic research. 2010, Vol 71, Num 1, pp 78-88, issn 0011-393X, 11 p.Article

The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjectsKADOKURA, Takeshi; DEN ADEL, Martin; KRAUWINKEL, Walter J. J et al.European journal of clinical pharmacology. 2008, Vol 64, Num 7, pp 691-695, issn 0031-6970, 5 p.Article

Comparison of the prophylactic anti―emetic efficacy of ramosetron and ondansetron in patients at high―risk for postoperative nausea and vomiting after total knee replacementHAHM, T. S; KO, J. S; CHOI, S. J et al.Anaesthesia. 2010, Vol 65, Num 5, pp 500-504, issn 0003-2409, 5 p.Article

Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgeryFUJII, Y; SAITOH, Y; TANAKA, H et al.Anesthesia and analgesia. 2000, Vol 90, Num 2, pp 472-475, issn 0003-2999Article

Oral formulations of the selective Serotonin₃ antagonists ramosetron (intraoral disintegrator formulation) and granisetron hydrochloride (standard tablet) in treating acute chemotherapy-induced emesis, nausea, and anorexia: A multicenter, randomized, single-blind, crossover, comparison studyFENG YI FENG; PIN ZHANG; YOU JIAN HE et al.Current therapeutic research. 2002, Vol 63, Num 11, pp 725-735, issn 0011-393X, 11 p.Article

Mucoadhesive suppositories of ramosetron hydrochloride utilizing Carbopol®YAHAGI, R; MACHIDA, Y; H et al.International journal of pharmaceutics. 2000, Vol 193, Num 2, pp 205-212, issn 0378-5173Article

The safety of novel drugs used to treat irritable bowel syndromeMOZAFFARI, Shilan; NIKFAR, Shekoufeh; ABDOLLAHI, Mohammad et al.Expert opinion on drug safety. 2014, Vol 13, Num 5, pp 625-638, issn 1474-0338, 14 p.Article

Contribution of P-glycoprotein to efflux of ramosetron, a 5-HT₃ receptor antagonist, across the blood-brain barrierYAMAMOTO, Chika; MURAKAMI, Hideyasu; SAWADA, Yasufumi et al.Journal of pharmacy and pharmacology. 2002, Vol 54, Num 8, pp 1055-1063, issn 0022-3573Article

Prevention of vomiting after tonsillectomy in children: Granisetron versus RamosetronFUJII, Yoshitaka; SAITOH, Yuhji; KOBAYASHI, Noriaki et al.The Laryngoscope. 2001, Vol 111, Num 2, pp 255-258, issn 0023-852XArticle

Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndromeMANNING, David D; CIOFFI, Christopher L; NAGINSKAYA, Jennifer et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 1, pp 58-61, issn 0960-894X, 4 p.Article

Antiemetic effect of ramosetron during hyperthermo-chemo-radiotherapy for esophageal cancerMORITA, Masaru; KUWANO, Hiroyuki; OHNO, Shinji et al.Anticancer research. 2000, Vol 20, Num 5C, pp 3631-3636, issn 0250-7005Article

Novel 5-hydroxytryptamine (5-HT₃) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivativesOHTA, M; SUZUKI, T; FURUYA, T et al.Chemical and pharmaceutical bulletin. 1996, Vol 44, Num 9, pp 1707-1716, issn 0009-2363Article

Discovery of 2-substituted benzoxazole carboxamides as 5-HT₃ receptor antagonistsZHICAI YANG; FAIRFAX, David J; HARDING, James P et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 22, pp 6538-6541, issn 0960-894X, 4 p.Article

Two-week oral mucosal irritation study with ramosetron orally disintegrating tablets in Syrian hamstersCUMMINS, H. A; TABATA, H; SUZUKI, H et al.Arzneimittel-Forschung. 1996, Vol 46, Num 7, pp 673-676, issn 0004-4172Article